Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEHIS study of nebivolol + hydrochlorothiazide versus irbesartan + hydrochlorothiazide in elderly patients with isolated systolic hypertension
NL-OMON36031Phase 4Active, not recruiting
- Sponsor
- Menarini International Operations Luxembourg S.A : Mr. Alessandro Casini
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in isolated systolic hypertension (ISH) comparing Nebivolol + hydrochlorothiazide with Irbesartan + hydrochlorothiazide (2 arms). Primary endpoint: Change in systolic blood pressure from baseline to Day 84. Started Nov 2011; status: active, not recruiting.
02
Drugs
nebivololhydrochlorothiazideirbesartan
03
Conditions
isolated systolic hypertension (ISH)
Beyond the preview
Go deeper on NL-OMON36031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36031.